3NT Medical Overview
h13NT Medical develops the Sinusway single-use steerable endoscope, which enables minimally invasive access, visualization, and treatment of the farthest reaches of the nasal anatomy and aims to improve the diagnosis and treatment of nasal disorders across all care settings.
Cumulative Funding Raised Over Time ($)
$1.0MFeb 2014
$16.0MMay 2018
$20.5MSep 2015
Latest News
growth-positive
3NT Medical Announces FDA Clearance for Colibri™ Endoscopy System
3NT Medical has received FDA 510(k) clearance for the Colibri Micro ENT Scope, the worlds first single-use endoscope designed for Otology. The Colibri endoscopy system allows for two-handed functionality in a single device and eliminates the risk of cross-contamination. The company aims to commercialize a full portfolio of single-use endoscopes to improve clinical outcomes and patient quality of life. 3NT Medical is an Israeli medical device technology leader with a U.S. sales and distribution subsidiary.
Customers
growth-positive
Japan's Hoya Corporation Invests in Endoscopy Company 3NT Medical
Israel-based medical technology company 3NT Medical Ltd. has closed a major portion of its $15 million target funding round, with Tokyo-headquartered Hoya Corporation leading the round. 3NT Medical will use the funding to develop and commercialize its products. Hoya Corporation, a manufacturer and supplier of ocular products and devices, reported revenues of $4.28 billion and a net income of $776 million for the fiscal year 2017. This is the corporations first venture investment in an Israeli company.
Investment
growth-positive
Israeli Endoscopy Startup 3NT Medical Announces Initial Closing of $15M to Include Key Strategic Investor
3NT Medical has announced the initial closing of a major portion of its $15 million financing round from HOYA Corporation. The funds will be used to complete 3NTs family of speciality single-use endoscopes and therapeutic devices and initiate commercialization of the SinuswayTM platform in the U.S. and Europe. This investment by HOYA Corporation validates 3NTs efforts to establish single-use endoscopy platforms as the next standard of care in ENT. HOYA Corporation is a global med-tech company and the leading supplier of innovative high-tech and medical products.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $20.5M |
| Last funding | $15M |
| Stage | Mature |
| Rounds | 3 |
| Investors | 1 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | 3ntmedical.com |
Locations
HaMelacha St 22, Rosh Haayin, Israel
830 Morris Turnpike, Short Hills, NJ, USA
Photos & Videos
1 item(s)
3NT Medical Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDiagnostics DevicesTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
—Tags (10)
healthcare-providersminimally-invasivehospitalsdiagnosticssurgerymedical-devicesendoscopyclinicstreatmentsmedical-technologiesGeographic Markets
Global3NT Medical Financials
$20.5M
Total funding
Undisclosed
Capital raised
$15M
Last funding
Mature
Funding stage
3
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$1.0MFeb 2014
$16.0MMay 2018
$20.5MSep 2015
Private Equity Funding
C Round
May 2018
$15M
Hoya Corporation
B Round
Sep 2015
$4.5M
A Round
Feb 2014
$1M
3NT Medical Lifecycle
Cumulative Funding Raised Over Time
$1.0MFeb 2014
$16.0MMay 2018
$20.5MSep 2015
All Events
C Round
May 2018
$15M
Hoya Corporation
B Round
Sep 2015
$4.5M
A Round
Feb 2014
$1M
3NT Medical News
3 articles
growth-positive
3NT Medical Announces FDA Clearance for Colibri™ Endoscopy System
3NT Medical has received FDA 510(k) clearance for the Colibri Micro ENT Scope, the worlds first single-use endoscope designed for Otology. The Colibri endoscopy system allows for two-handed functionality in a single device and eliminates the risk of cross-contamination. The company aims to commercialize a full portfolio of single-use endoscopes to improve clinical outcomes and patient quality of life. 3NT Medical is an Israeli medical device technology leader with a U.S. sales and distribution subsidiary.
Customers
growth-positive
Japan's Hoya Corporation Invests in Endoscopy Company 3NT Medical
Israel-based medical technology company 3NT Medical Ltd. has closed a major portion of its $15 million target funding round, with Tokyo-headquartered Hoya Corporation leading the round. 3NT Medical will use the funding to develop and commercialize its products. Hoya Corporation, a manufacturer and supplier of ocular products and devices, reported revenues of $4.28 billion and a net income of $776 million for the fiscal year 2017. This is the corporations first venture investment in an Israeli company.
Investment
growth-positive
Israeli Endoscopy Startup 3NT Medical Announces Initial Closing of $15M to Include Key Strategic Investor
3NT Medical has announced the initial closing of a major portion of its $15 million financing round from HOYA Corporation. The funds will be used to complete 3NTs family of speciality single-use endoscopes and therapeutic devices and initiate commercialization of the SinuswayTM platform in the U.S. and Europe. This investment by HOYA Corporation validates 3NTs efforts to establish single-use endoscopy platforms as the next standard of care in ENT. HOYA Corporation is a global med-tech company and the leading supplier of innovative high-tech and medical products.
Investment
3NT Medical Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 20 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
3NT Medical Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Yotam Maman |
| Registrar ID | 514885201 |
| Crunchbase | 3nt-medical-ltd |
| Phone | +972737154057 |
| Creator | Ehud Bendory |
| Creator email | ehudbendory@gmail.com |
| Last updater | Orli Wollner |
| Updater email | orlushka@gmail.com |
| Last update | 2020-10-07T00:00:00.000Z |
| Created | 2018-05-07T00:00:00.000Z |
| Claimed | Yes |